Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...
Stockhead on MSN3d
Health Check: Despite a ‘biggest ever’ December half, Pro Medicus says it’s just revving up in the USOn the back of US contract wins, home-grown radiology giant Pro Medicus reports a record December half with the promise of ...
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
People are warning each other about an alleged recall on chicken and Eggland's Best eggs that's not based in reality.
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the initiation of VALUE, a global, pivotal Phase III trial evaluating ...
These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...
Under the approval process, the FDA has 180 days to review a pre-market ... just down the road from its current digs. The “very favourable” terms” on the 11-year lease include a one-year ...
Gov. JB Pritzker will present his seventh budget proposal Wednesday as the state faces a projected $3.2 billion revenue ...
On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback